Summary Information:
Recursion Pharmaceuticals Inc. Class A Common Stock
NASDAQ:RXRX


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Recursion Pharmaceuticals Inc. Class A Common Stock
Exchange: NASDAQ
Symbol: RXRX
SEC CIK: 0001601830
Phone: (385) 269-0203
41S RIO GRANDE STREET
SALT LAKE CITY UT 84101

CEO:
Price when page updated: 7.3579 Date: 2023-12-01
Company Website:
www.recursionpharma.com

_Description: Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to its mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what Recursion believes is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that the company uses to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate its programs. biotechnology company scaling more like a technology company.\r

IPO YEAR:
2021
Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
1593892145.00
Beta:

52 Week High:
42.81
52 Week Low:
15.25
52 Week Change:
-0.4651757188498403
Short Interest:

Short Date:

Shares Outstanding:
159525190
Dividend Rate:
0
Dividend Yield:
12.26%
ExDividend Date:

Latest EPS:

Latest EPS Date:
26 Oct 2022
Float:
0
return on Equity:
-45.10%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$66.025M
ttmEPS:
0
Revenue:
$238.302M
Gross Profit:

Cash:

Debt:

Institution Percent:
81.70%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
6.20%
Return on Assets:
-35.00%
Return on Capital:

Profit Margin:
-
Price to Sales:
111.06
Price To Book:
4.30
Short Ratio:
15.81
PE Ratio:
0
Employees:
218
1Y Guesstimate
12.890:1.0:5




__The following are links to various summary and news pages for
__Recursion Pharmaceuticals Inc. Class A Common Stock [ RXRX ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-01